KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbCellera Biologics (ABCL) Long-Term Debt Issuances: 2019-2021

Historic Long-Term Debt Issuances for AbCellera Biologics (ABCL) over the last 3 years, with Dec 2021 value amounting to $872,000.

  • AbCellera Biologics' Long-Term Debt Issuances fell 52.71% to $3.1 million in Q3 2024 from the same period last year, while for Sep 2024 it was $14.2 million, marking a year-over-year increase of 140.84%. This contributed to the annual value of $872,000 for FY2021, which is 94.37% down from last year.
  • As of FY2021, AbCellera Biologics' Long-Term Debt Issuances stood at $872,000, which was down 94.37% from $15.5 million recorded in FY2020.
  • In the past 5 years, AbCellera Biologics' Long-Term Debt Issuances registered a high of $15.5 million during FY2020, and its lowest value of $193,000 during FY2019.
  • Its 3-year average for Long-Term Debt Issuances is $5.5 million, with a median of $872,000 in 2021.
  • As far as peak fluctuations go, AbCellera Biologics' Long-Term Debt Issuances skyrocketed by 7,925.91% in 2020, and later tumbled by 94.37% in 2021.
  • Over the past 3 years, AbCellera Biologics' Long-Term Debt Issuances (Yearly) stood at $193,000 in 2019, then soared by 7,925.91% to $15.5 million in 2020, then slumped by 94.37% to $872,000 in 2021.